SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

RBC Capital Initiates Coverage On Ionis Pharmaceuticals with Outperform Rating, Announces Price Target of $71

RBC Capital initiates coverage on Ionis Pharmaceuticals (NASDAQ:IONS) with a Outperform rating and announces Price Target of $71.

Benzinga · 05/13/2020 09:02

RBC Capital initiates coverage on Ionis Pharmaceuticals (NASDAQ:IONS) with a Outperform rating and announces Price Target of $71.